Author:
Shiraiwa Kazumi,Tsutsumi Masahiro,Konishi Yoichi
Publisher
Springer Berlin Heidelberg
Reference18 articles.
1. Bareity J, Bellon B, Sapin C, Kuhn J, Druet P, Hinglais N, Giraud JP, Belair MF, Paing M, Laliberte F (1981) Immunoenzymatic study of the protein pathway through the glomerular barrier in rat glomerulonephritides. Kidney Int 19:663–677
2. Bernard J, Paul R, Boiron M, Jacquillat CI, Maral R (eds) (1969) Rubidomycin: a new agent against cancer. Springer, Berlin Heidelberg New York, pp 100–101
3. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB (1982) Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46:16--23
4. Buja LM, Ferrans VJ, Mayer RJ, Roberts WC, Henderson ES (1973) Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32:771–788
5. Cameron JS, Turner DR, Ogg CS, Sharpstone P, Brown CB (1974) The nephrotic syndrome in adults with ‘minimal change’glomerular lesions. QJ Med 43:461–488